X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12456) 12456
Book Review (1768) 1768
Publication (887) 887
Conference Proceeding (55) 55
Magazine Article (14) 14
Book Chapter (10) 10
Dissertation (8) 8
Presentation (1) 1
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11786) 11786
index medicus (11574) 11574
deoxycytidine - analogs & derivatives (11222) 11222
female (7382) 7382
deoxycytidine - administration & dosage (6680) 6680
oncology (6612) 6612
male (6227) 6227
antineoplastic combined chemotherapy protocols - therapeutic use (6184) 6184
middle aged (6137) 6137
aged (5675) 5675
deoxycytidine - therapeutic use (4708) 4708
adult (4581) 4581
chemotherapy (4317) 4317
gemcitabine (4114) 4114
treatment outcome (3503) 3503
cancer (3328) 3328
capecitabine (2758) 2758
fluorouracil - analogs & derivatives (2676) 2676
deoxycytidine - adverse effects (2543) 2543
antimetabolites, antineoplastic - therapeutic use (2423) 2423
pancreatic neoplasms - drug therapy (2250) 2250
antineoplastic combined chemotherapy protocols - adverse effects (2168) 2168
fluorouracil - administration & dosage (2071) 2071
aged, 80 and over (1898) 1898
cisplatin - administration & dosage (1763) 1763
lung neoplasms - drug therapy (1752) 1752
pancreatic cancer (1672) 1672
cisplatin (1661) 1661
therapy (1620) 1620
animals (1608) 1608
pharmacology & pharmacy (1601) 1601
neoplasm staging (1549) 1549
pancreatic neoplasms - pathology (1438) 1438
care and treatment (1420) 1420
survival rate (1412) 1412
disease-free survival (1409) 1409
survival (1398) 1398
carcinoma, non-small-cell lung - drug therapy (1388) 1388
carcinoma (1385) 1385
drug administration schedule (1310) 1310
adenocarcinoma - drug therapy (1284) 1284
antineoplastic agents - therapeutic use (1247) 1247
cell line, tumor (1227) 1227
research (1226) 1226
trial (1226) 1226
deoxycytidine - pharmacology (1223) 1223
antimetabolites, antineoplastic - administration & dosage (1207) 1207
prognosis (1207) 1207
survival analysis (1187) 1187
fluorouracil - therapeutic use (1142) 1142
medicine & public health (1134) 1134
retrospective studies (1103) 1103
breast neoplasms - drug therapy (1083) 1083
mice (1061) 1061
combined modality therapy (1054) 1054
combination (1044) 1044
paclitaxel - administration & dosage (973) 973
organoplatinum compounds - administration & dosage (962) 962
adenocarcinoma (939) 939
metastasis (911) 911
neoplasm metastasis (904) 904
antimetabolites, antineoplastic - adverse effects (899) 899
antineoplastic combined chemotherapy protocols - administration & dosage (882) 882
analysis (881) 881
paclitaxel (877) 877
drug therapy (873) 873
5-fluorouracil (864) 864
dose-response relationship, drug (864) 864
tumors (852) 852
antineoplastic agents (845) 845
disease progression (794) 794
hematology, oncology and palliative medicine (790) 790
antimitotic agents (789) 789
chemotherapy, adjuvant (787) 787
clinical trials (778) 778
lung neoplasms - pathology (769) 769
fluorouracil - adverse effects (768) 768
oxaliplatin (748) 748
fluorouracil (728) 728
follow-up studies (722) 722
phase-ii (721) 721
radiotherapy (721) 721
surgery (709) 709
health aspects (704) 704
breast neoplasms - pathology (697) 697
phase-ii trial (697) 697
taxoids - administration & dosage (686) 686
expression (683) 683
docetaxel (670) 670
cancer research (664) 664
colorectal neoplasms - drug therapy (663) 663
apoptosis (656) 656
time factors (652) 652
carboplatin - administration & dosage (649) 649
adenocarcinoma - pathology (646) 646
kaplan-meier estimate (639) 639
camptothecin - analogs & derivatives (635) 635
breast cancer (617) 617
vinblastine - analogs & derivatives (613) 613
drug resistance, neoplasm (601) 601
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11302) 11302
Japanese (610) 610
Chinese (154) 154
French (139) 139
German (85) 85
Spanish (41) 41
Italian (33) 33
Russian (33) 33
Hungarian (15) 15
Dutch (12) 12
Korean (11) 11
Czech (10) 10
Polish (6) 6
Lithuanian (5) 5
Romanian (4) 4
Danish (3) 3
Hebrew (3) 3
Bosnian (1) 1
Norwegian (1) 1
Portuguese (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Infectious Diseases, The, ISSN 1473-3099, 2015, Volume 15, Issue 7, pp. 775 - 784
Summary Background Problems associated with lifelong antiretroviral therapy, such as need for strict adherence, drug-related toxic effects, difficulties with... 
Infectious Disease | INFECTIOUS DISEASES | ABACAVIR-LAMIVUDINE | EFFICACY | SAFETY | NAIVE HIV-1-INFECTED PATIENTS | ACTIVE ANTIRETROVIRAL THERAPY | ONCE-DAILY ATAZANAVIR/RITONAVIR | TWICE-DAILY LOPINAVIR/RITONAVIR | INFECTED PATIENTS | PROTEASE INHIBITORS | TENOFOVIR | HIV-1 | Humans | Middle Aged | Male | RNA, Viral - blood | Viral Load | Oligopeptides - therapeutic use | Reverse Transcriptase Inhibitors - adverse effects | Tenofovir | Deoxycytidine - therapeutic use | Drug Therapy, Combination - adverse effects | Adenine - therapeutic use | Lamivudine - therapeutic use | Atazanavir Sulfate | Ritonavir - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Reverse Transcriptase Inhibitors - therapeutic use | Pyridines - therapeutic use | Emtricitabine | HIV Protease Inhibitors - adverse effects | Adenine - analogs & derivatives | Organophosphonates - therapeutic use | Anti-HIV Agents - adverse effects | HIV Infections - virology | HIV Protease Inhibitors - therapeutic use | Drug Therapy, Combination - methods | HIV Infections - drug therapy | Zidovudine - therapeutic use | Drug Substitution | Deoxycytidine - analogs & derivatives | Studies | Antiretroviral drugs | Heart attacks | Protease inhibitors | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Clinical trials | Infections | Mutation | Drug therapy | Failure | Cost control | Index Medicus
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 7/2013, Volume 208, Issue 1, pp. 32 - 39
Background. Cobicistat (COBI) is a pharmacoenhancer with no antiretroviral activity in vitro. Methods. An international, randomized, double-blind,... 
T lymphocytes | HIV/AIDS | Antiretrovirals | Infectious diseases | RNA | HIV | Drug evaluation | AIDS | Photographs | HIV 1 | Virology | cobicistat | pharmacoenhancer | INFECTIOUS DISEASES | CO-FORMULATED ELVITEGRAVIR | RENAL-FUNCTION | INITIAL TREATMENT | MICROBIOLOGY | HIV-1-INFECTED PATIENTS | IMMUNOLOGY | DAILY LOPINAVIR/RITONAVIR | GLOMERULAR-FILTRATION-RATE | EFAVIRENZ | DOUBLE-BLIND | ONCE-DAILY DARUNAVIR/RITONAVIR | TENOFOVIR | Humans | Male | Thiazoles - administration & dosage | Carbamates - administration & dosage | Thiazoles - therapeutic use | Oligopeptides - therapeutic use | Anti-HIV Agents - administration & dosage | Tenofovir | Deoxycytidine - therapeutic use | Adenine - therapeutic use | Atazanavir Sulfate | Ritonavir - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Drug Therapy, Combination | Pyridines - therapeutic use | Emtricitabine | Adenine - analogs & derivatives | Pyridines - administration & dosage | Double-Blind Method | Organophosphonates - therapeutic use | Ritonavir - administration & dosage | HIV-1 - drug effects | Deoxycytidine - administration & dosage | Treatment Outcome | HIV Protease Inhibitors - administration & dosage | HIV Protease Inhibitors - therapeutic use | Adenine - administration & dosage | Organophosphonates - administration & dosage | HIV Infections - drug therapy | Oligopeptides - administration & dosage | Carbamates - therapeutic use | Viral Load - drug effects | Cobicistat | Deoxycytidine - analogs & derivatives | Research | Drug therapy | HIV infection | Patient outcomes | Index Medicus | Abridged Index Medicus
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9787, pp. 229 - 237
Summary Background The non-nucleoside reverse transcriptase inhibitor (NNRTI), rilpivirine (TMC278; Tibotec Pharmaceuticals, County Cork, Ireland), had... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | ZIDOVUDINE | COMBINATION THERAPY | ACTIVE ANTIRETROVIRAL THERAPY | EMTRICITABINE | PROTEASE-INHIBITOR | CYSTATIN-C | CREATININE | DAILY LAMIVUDINE | NEVIRAPINE | TENOFOVIR | Rilpivirine | HIV Reverse Transcriptase - antagonists & inhibitors | Humans | Middle Aged | Male | Anti-HIV Agents - administration & dosage | Nitriles - administration & dosage | Tenofovir | Deoxycytidine - therapeutic use | Nucleotides - therapeutic use | Adenine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Reverse Transcriptase Inhibitors - therapeutic use | Acquired Immunodeficiency Syndrome - virology | Acquired Immunodeficiency Syndrome - ethnology | Emtricitabine | Nucleosides - therapeutic use | Adenine - analogs & derivatives | Benzoxazines - administration & dosage | Double-Blind Method | Drug Administration Schedule | Organophosphonates - therapeutic use | HIV-1 - drug effects | Pyrimidines - administration & dosage | Anti-HIV Agents - adverse effects | Benzoxazines - adverse effects | Treatment Outcome | HIV-1 - genetics | Acquired Immunodeficiency Syndrome - drug therapy | Benzoxazines - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Mutation | Nitriles - adverse effects | Viral Load - drug effects | Deoxycytidine - analogs & derivatives | Nitriles - therapeutic use | Evaluation | Patient outcomes | Clinical trials | Dosage and administration | Drug therapy | HIV infection | Design | Antiretroviral drugs | Corporate sponsorship | Human immunodeficiency virus--HIV | Technological change | Research | Clinical medicine | Drugs | RNA-directed DNA polymerase | Exanthema | antiretroviral therapy | Lamivudine | Lipids | Nucleotides | Regression analysis | Efavirenz | CD4 antigen | nucleosides | Algorithms | Hospitals | non-nucleoside reverse transcriptase inhibitors | Abacavir | Zidovudine | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 10/2014, Volume 161, Issue 7, pp. 461 - 471
Journal Article
Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 04/2013, Volume 62, Issue 5, pp. 483 - 486
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9787, pp. 238 - 246
Summary Background Efavirenz with tenofovir-disoproxil-fumarate and emtricitabine is a preferred antiretroviral regimen for treatment-naive patients infected... 
Internal Medicine | LAMIVUDINE | MEDICINE, GENERAL & INTERNAL | EFFICACY | SAFETY | COMBINATION THERAPY | GUIDELINES | PROTEASE-INHIBITOR | ANTIRETROVIRAL THERAPY | NEVIRAPINE | REGIMENS | Rilpivirine | HIV Reverse Transcriptase - antagonists & inhibitors | Humans | Middle Aged | Male | Anti-HIV Agents - administration & dosage | Nitriles - administration & dosage | Tenofovir | Deoxycytidine - therapeutic use | Adenine - adverse effects | Adenine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Deoxycytidine - adverse effects | Female | Reverse Transcriptase Inhibitors - therapeutic use | Acquired Immunodeficiency Syndrome - virology | Acquired Immunodeficiency Syndrome - ethnology | Emtricitabine | Adenine - analogs & derivatives | Benzoxazines - administration & dosage | Double-Blind Method | Drug Administration Schedule | Organophosphonates - therapeutic use | HIV-1 - drug effects | Pyrimidines - administration & dosage | Anti-HIV Agents - adverse effects | Deoxycytidine - administration & dosage | Organophosphonates - adverse effects | Benzoxazines - adverse effects | Treatment Outcome | HIV-1 - genetics | Acquired Immunodeficiency Syndrome - drug therapy | Adenine - administration & dosage | Benzoxazines - therapeutic use | Organophosphonates - administration & dosage | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Aged | Mutation | Nitriles - adverse effects | Viral Load - drug effects | Deoxycytidine - analogs & derivatives | Nitriles - therapeutic use | Dosage and administration | Efavirenz | Patient outcomes | Clinical trials | Antiretroviral drugs | Drug therapy | Human immunodeficiency virus--HIV | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2013, Volume 369, Issue 18, pp. 1691 - 1703
Journal Article
Journal Article
11.